Stocks News

LAST PRICE
201.8200
TODAY'S CHANGE (%)
Trending Up4.2200 (2.1356%)

Bid / Lots
193.4800/ 1
Ask / Lots
208.6300/ 2
Open / Previous Close
197.0300 / 197.6000
Day Range
Low 196.3300
High 203.0200
52 Week Range
Low 187.6200
High 261.7300
Volume
1,886,722
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 19, 2024
- DJ IQVIA Holdings Price Target Cut to $248.00/Share From $260.00 by Leerink Partners, from 10:48AM ET on Tuesday Nov 19, 2024 by Dow Jones
  10:48AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: IQV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IQV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 19, 2024 10:48 ET (15:48 GMT)
- Leerink Adjusts Price Target on IQVIA Holdings to $248 From $260, Maintains Outperform Rating, from 6:44AM ET on Tuesday Nov 19, 2024 by MT Newswires
  6:44AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: IQV
  06:44 AM EST, 11/19/2024 (MT Newswires) -- IQVIA Holdings (IQV) has an average rating of overweight and mean price target of $248.85, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major ba...
Nov 6, 2024
- IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024, from 4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones
  4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: IQV
  
  IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
  RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--November 06, 2024--
  IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos Verdes, California on Wednesday, November 13, 2024 at 1:15 p.m. ET.
- Argus Cuts Price Target on IQVIA to $260 From $280, from 7:53AM ET on Wednesday Nov 06, 2024 by MT Newswires
  7:53AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: IQV
  07:53 AM EST, 11/06/2024 (MT Newswires) -- IQVIA Holdings Inc (IQV) has an average rating of outperform and price targets ranging from $195 to $290, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic rese...
Nov 5, 2024
- DJ IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital, from 11:34AM ET on Tuesday Nov 05, 2024 by Dow Jones
  11:34AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: IQV
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IQV/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 11:34 ET (16:34 GMT)

Today
- DJ Moderna Up Over 10%, Best Performer in the S&P 500 and Nasdaq 100 So Far Today -- Data Talk, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: MRNA
Yesterday
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR), from 2:08PM ET on Thursday Nov 21, 2024 by Accesswire
  2:08PM ET on Thursday Nov 21, 2024 by Accesswire
  Companies Mentioned: ICLR
- DJ Biogen Is Maintained at Outperform by Mizuho, from 8:18AM ET on Thursday Nov 21, 2024 by Dow Jones
  8:18AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: BIIB
- Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR), from 7:25AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:25AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: ICLR
Nov 20, 2024
- DJ Biogen On Pace For Lowest Close Since February 2013 -- Data Talk, from 10:54AM ET on Wednesday Nov 20, 2024 by Dow Jones
  10:54AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: BIIB
- Mizuho Securities Adjusts Price Target on Biogen to $207 From $251, from 10:13AM ET on Wednesday Nov 20, 2024 by MT Newswires
  10:13AM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: BIIB
- DJ Icon Is Maintained at Neutral by Baird, from 7:35AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:35AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: ICLR
- Levi & Korsinsky Announces an Investigation on Behalf of ICON Public Limited Company (ICLR) Shareholders Who May Have Been Affected by Fraud, from 7:26AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:26AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: ICLR
- Baptista Upgrades Moderna to Buy, Price Target at $48, from 5:17AM ET on Wednesday Nov 20, 2024 by MT Newswires
  5:17AM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: MRNA
Nov 19, 2024
- DJ BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com, from 11:57AM ET on Tuesday Nov 19, 2024 by Dow Jones
  11:57AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: NVAX, PFE, MRNA, BNTX

IQVIA Holdings Inc
NYSE:IQVUnited States

Search Criteria

Nov 19, 2024

DJ IQVIA Holdings Price Target Cut to $248.00/Share From $260.00 by Leerink Partners, from 10:48AM ET on Tuesday Nov 19, 2024 by Dow Jones

Leerink Adjusts Price Target on IQVIA Holdings to $248 From $260, Maintains Outperform Rating, from 6:44AM ET on Tuesday Nov 19, 2024 by MT Newswires

Nov 6, 2024

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024, from 4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones

Argus Cuts Price Target on IQVIA to $260 From $280, from 7:53AM ET on Wednesday Nov 06, 2024 by MT Newswires

Nov 5, 2024

DJ IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital, from 11:34AM ET on Tuesday Nov 05, 2024 by Dow Jones

Peers Headlines

Today

DJ Moderna Up Over 10%, Best Performer in the S&P 500 and Nasdaq 100 So Far Today -- Data Talk, from 7 hours ago by Dow Jones

Yesterday

Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR), from 2:08PM ET on Thursday Nov 21, 2024 by Accesswire

DJ Biogen Is Maintained at Outperform by Mizuho, from 8:18AM ET on Thursday Nov 21, 2024 by Dow Jones

Levi & Korsinsky Investigates Possible Securities Fraud Violations by ICON Public Limited Company (ICLR), from 7:25AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ Biogen On Pace For Lowest Close Since February 2013 -- Data Talk, from 10:54AM ET on Wednesday Nov 20, 2024 by Dow Jones

Mizuho Securities Adjusts Price Target on Biogen to $207 From $251, from 10:13AM ET on Wednesday Nov 20, 2024 by MT Newswires

DJ Icon Is Maintained at Neutral by Baird, from 7:35AM ET on Wednesday Nov 20, 2024 by Dow Jones

Levi & Korsinsky Announces an Investigation on Behalf of ICON Public Limited Company (ICLR) Shareholders Who May Have Been Affected by Fraud, from 7:26AM ET on Wednesday Nov 20, 2024 by Dow Jones

Baptista Upgrades Moderna to Buy, Price Target at $48, from 5:17AM ET on Wednesday Nov 20, 2024 by MT Newswires

Nov 19, 2024

DJ BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com, from 11:57AM ET on Tuesday Nov 19, 2024 by Dow Jones